496 results on '"Batchelor, Hannah"'
Search Results
2. Compatibility of Caco-2 cells with simulated intestinal fluid-predicting permeability
3. Pharmaceutical science - transLating innovation for delivery to patients: The 14th APS PharmSci International Conference
4. Study of in-vitro poorly soluble drug solubility into fasted state simulated intestinal fluid reflective of in vivo gastrointestinal variability
5. Using Mechanistic Modeling Approaches to Support Bioequivalence Assessments for Oral Products
6. Changes in Methadone Regulation During COVID-19
7. Method development for quantification of DMET-proteins in the paediatric intestinal tract via LC-MS/MS using a QconCAT technique
8. Pharmaceutical science in a post-covid-19 world: The 13th APS PharmSci international conference
9. Solubility measurement of poorly soluble drugs in fasted state simulated intestinal fluid reflective of in-vivo gastrointestinal variability
10. Characterisation of colloidal structures and their solubilising potential for BCS class II drugs in fasted state simulated intestinal fluid
11. A novel simulated media system for in vitro evaluation of bioequivalent intestinal drug solubility
12. The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use
13. The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration
14. Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19
15. Past experience shapes the neural circuits recruited for future learning
16. Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique
17. Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study
18. Solid lipid nanoparticles and nanostructured lipid carriers of dual functionality at emulsion interfaces. Part II: active carrying/delivery functionality
19. Solid lipid nanoparticles and nanostructured lipid carriers of dual functionality at emulsion interfaces. Part I: Pickering stabilisation functionality
20. Drugs for neglected tropical diseases: availability of age-appropriate oral formulations for young children
21. Medicine manipulation for paediatric use: Dispersible aspirin tablets and dose uniformity
22. A review of in vitro and in vivo methods and their correlations to assess mouthfeel of solid oral dosage forms
23. Neurotensin Receptor-1 Identifies a Subset of Ventral Tegmental Dopamine Neurons that Coordinates Energy Balance.
24. Grief at the Heart of the Opioid Overdose Crisis: Past Lessons and Present Implications
25. Combining data on the bioavailability of midazolam and physiologically‐based pharmacokinetic modeling to investigate intestinal CYP3A4 ontogeny.
26. Biopharmaceutics: From Fundamentals to Industrial Practice
27. Prophylactic perioperative cefuroxime levels in plasma and adipose tissue at the time of caesarean section (C-LACE): a protocol for a pilot experimental, prospective study with non-probability sampling to determine interpatient variability
28. Efficacy of perioperative cefuroxime as a prophylactic antibiotic in women requiring caesarean section: A systematic review
29. Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products
30. Physico-chemical, antimicrobial and antioxidant properties of gelatin-chitosan based films loaded with nanoemulsions encapsulating active compounds
31. Determination of neurotensin projections to the ventral tegmental area in mice
32. Colour of Medicines and Children’s Acceptability? A Systematic Literature Review of Children’s Perceptions about Colours of Oral Dosage Forms
33. Optimizing expert and patient input in pediatric trial design: Lessons learned and recommendations from a collaboration between conect4children and European Patient‐CEntric ClinicAl TRial PLatforms
34. Dopamine transients do not act as model-free prediction errors during associative learning
35. Chapter 22 - Pediatric drug formulations
36. An investigation into the adhesion of alginate solutions in œsophageal tissue
37. Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline
38. Optimizing expert and patient input in pediatric trial design:Lessons learned and recommendations from a collaboration between conect4children and European Patient-CEntric ClinicAl TRial PLatforms
39. Towards the development of a paediatric biopharmaceutics classification system: Results of a survey of experts
40. Pharmacy and formulation support for paediatric clinical trials in England
41. Use of PLIF to assess the mixing performance of small volume USP 2 apparatus in shear thinning media
42. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study
43. Nasal, Ocular and Otic Drug Delivery
44. Rectal Drug Delivery
45. Paediatric Development: Gastrointestinal
46. Paediatric Development: Anatomy. Age, Weight, Body Surface and Stature, Organ Development
47. Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software
48. Understanding the impact of media viscosity on dissolution of a highly water soluble drug within a USP 2 mini vessel dissolution apparatus using an optical planar induced fluorescence (PLIF) method
49. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population
50. The application of tribology in assessing texture perception of oral liquid medicines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.